Literature DB >> 1937467

Cytogenetic studies in leprosy patients before and after chemotherapy.

D D'Souza1, B C Das, I M Thomas.   

Abstract

The frequencies of chromosome aberrations and sister chromatid exchanges (SCEs), cell proliferation kinetics and mitotic indices were studied in peripheral blood lymphocyte cultures of leprosy patients both before and after chemotherapy. The differences in the frequencies of chromosome aberrations and SCEs between controls, paucibacillary and multibacillary patients were found to be statistically highly significant (P less than 0.001). The extent of cytogenetic damage seemed to depend on the severity of the disease. Lymphocytes of untreated leprosy patients showed a low mitotic index and a slow rate of cell proliferation. Following combined treatment with dapsone and rifampicin there was an increase, but to a lesser degree (P less than 0.01), in the frequency of SCEs and chromosome aberrations while the drug combination of dapsone, rifampicin and clofazamine had a nonmutagenic effect on chromosomes of the patient. Furthermore, after drug treatment, the cell proliferation rate and mitotic indices in paucibacillary patients were comparable to that of controls. These results indicate the clastogenic potency of Mycobacterium leprae and the remedial effects that follow therapeutic drug treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937467     DOI: 10.1007/bf00201722

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test.

Authors:  C K Job; C J Chacko; P M Taylor; M Daniel; G Jesudian
Journal:  Int J Lepr Other Mycobact Dis       Date:  1976 Jan-Jun

2.  Chromosome aberrations and sister chromatid exchanges (SCEs) in peripheral blood lymphocyte cultures of untreated leprosy patients.

Authors:  D D'Souza; I M Thomas
Journal:  Lepr Rev       Date:  1988-06       Impact factor: 0.537

3.  Influence of chemotherapy and serum factors on the mitogenic response of peripheral leucocytes of leprosy patients to phytohaemagglutinin.

Authors:  V L Mehra; G P Talwar; K Balakrishnan; L K Bhutani
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

4.  Phytohaemagglutinin-induced lymphocyte transformation in leprosy.

Authors:  D S Nelson; M Nelson; J M Thurston; M F Waters; J M Pearson
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

5.  The cytogenetic effects of mycoplasma in human leukocyte cultures.

Authors:  P Aula; W W Nichols
Journal:  J Cell Physiol       Date:  1967-12       Impact factor: 6.384

6.  Leprosy in a mangabey monkey--naturally acquired infection.

Authors:  W M Meyers; G P Walsh; H L Brown; C H Binford; G D Imes; T L Hadfield; C J Schlagel; Y Fukunishi; P J Gerone; R H Wolf
Journal:  Int J Lepr Other Mycobact Dis       Date:  1985-03

7.  Status of T and B lymphocytes in peripheral blood.

Authors:  P K Singh; P K Jain; V P Mital
Journal:  Lepr India       Date:  1983-07

8.  Simple differential Giemsa staining of sister chromatids after treatment with photosensitive dyes and exposure to light and the mechanism of staining.

Authors:  K Goto; T Akematsu; H Shimazu; T Sugiyama
Journal:  Chromosoma       Date:  1975-12-10       Impact factor: 4.316

9.  Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response.

Authors:  W E Bullock; P Fasal
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

10.  Chromosome changes in human diploid-cell cultures infected with Mycoplasma.

Authors:  G R Paton; J P Jacobs; F T Perkins
Journal:  Nature       Date:  1965-07-03       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.